Tag: Patents
Federal Circuit Clarifies Limits of Prosecution Disclaimer in Maquet v. Abiomed Patent Dispute
March 21, 2025
Maquet Cardiovascular LLC v. Abiomed Inc. Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit vacated a lower court’s ruling in the patent dispute between Maquet Cardiovascular LLC and Abiomed Inc., providing important guidance on how prosecution…
Read MoreFederal Circuit Clarifies Limits on Raising New Arguments in Patent Appeals
March 19, 2025
AMP Plus, Inc. v. DMF, Inc Authored by: Jeremy J. Gustrowsky In AMP Plus, Inc. v. DMF, Inc., the Federal Circuit recently affirmed a decision by the Patent Trial and Appeal Board (PTAB) regarding a dispute over U.S. Patent No.…
Read MoreFederal Circuit Clarifies: Patent Claims Listing Separate Ingredients Require Separate Components
March 14, 2025
Regeneron Pharms., Inc. v. Mylan Pharms. Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed that when a patent claim lists components separately—like a “VEGF antagonist” and a “buffer”—those elements must be distinct in the…
Read MoreJepson Claims Face Higher Written Description Bar in In re Xencor, Inc.
March 13, 2025
In re Xencor, Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed the rejection of Xencor, Inc.’s patent application (U.S. Patent Application No. 16/803,690) for failing to provide an adequate written description, particularly focusing on…
Read MoreUnderstanding Patents and Trademarks: Key Protections for Innovation and Branding
March 12, 2025
A patent is essentially a government-granted right that allows the holder to prevent others from making, using, selling, or importing a particular invention for a set period of time. This protection encourages innovation by ensuring that inventors have exclusive rights…
Read MoreFederal Circuit Vacates PTAB Decision in CQV v. Merck Over Prior Art Evidence
March 10, 2025
CQV Co., Ltd. v. Merck Pat. GmbH Authored by: Jeremy J. Gustrowsky In the recent case of CQV Co., Ltd. v. Merck Patent GmbH, the Federal Circuit addressed a dispute over the validity of U.S. Patent No. 10,647,861, which covers…
Read MorePatent Board’s Ruling Vacated Over Expert Qualifications and Claim Interpretation in Sierra Wireless v. Sisvel
March 10, 2025
Sierra Wireless v. Sisvel S.P.A Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit vacated a Patent Trial and Appeal Board (PTAB) ruling that had found several claims of U.S. Patent No. 7,869,396 unpatentable. The patent, owned…
Read MoreFederal Circuit Affirms PTAB’s Finding of Obviousness in AliveCor v. Apple Patent Dispute
March 7, 2025
Alivecor, Inc. v. Apple Inc Authored by: Jeremy J. Gustrowsky In a closely watched case, the Federal Circuit has affirmed the Patent Trial and Appeal Board’s (PTAB) decision that all claims of three AliveCor patents related to wearable heart monitoring…
Read MoreFederal Circuit Clarifies “Pull Cord” in Tactical Vest Patent Dispute
March 7, 2025
IQRIS Techs. LLC v. Point Blank Enters Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit addressed how the term “pull cord” should be interpreted in a patent dispute between IQRIS Technologies LLC and Point Blank Enterprises,…
Read MoreFederal Circuit Affirms Obviousness Ruling for ImmunoGen’s Cancer Drug Dosing Patent Application
March 6, 2025
ImmunoGen, Inc. v. Stewart Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed that ImmunoGen, Inc. was not entitled to a patent for a specific dosing regimen of its cancer drug, IMGN853 (mirvetuximab soravtansine), used to…
Read MoreCourt Clarifies What Counts as “Domestic Industry” for Patent Protection at the ITC
March 5, 2025
Lashify, Inc. v. Int’l Trade Comm’n Authored by: Jeremy J. Gustrowsky In a significant decision for patent owners who manufacture their products overseas, the Federal Circuit in Lashify, Inc. v. International Trade Commission clarified what activities can qualify as a…
Read MoreApple, LG, and Google Succeed in Invalidating Most Gesture Tech Patent Claims, but Two Survive
March 4, 2025
Apple Inc. v. Gesture Tech. Partners, LLC Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed a ruling by the Patent Trial and Appeal Board (PTAB) that invalidated most claims of U.S. Patent No. 7,933,431, owned…
Read More